Discontinuation of Long-Term Pseudoephedrine Use

Risks and Recommendations

The American College of Cardiology recommends that patients who have been taking pseudoephedrine for one year should discontinue the medication and consider alternative therapies due to potential cardiovascular risks and limited evidence for long-term use 1, 2
Pseudoephedrine is a sympathomimetic drug that can cause elevated blood pressure through its vasoconstrictor activity, making it unsuitable for extended use 1, 2

A gradual taper is recommended rather than abrupt discontinuation for patients who have been taking pseudoephedrine for an extended period, with a dose reduction of approximately 10% per week to minimize potential withdrawal symptoms 3
The American Heart Association, as published in Circulation, suggests monitoring for signs of adrenergic hyperactivity during the tapering process, including changes in blood pressure and heart rate 2
Complete discontinuation should be achieved within 4-6 weeks for most patients, as recommended by the Mayo Clinic Proceedings 3

The American College of Cardiology recommends considering safer alternative therapies for nasal congestion, such as nasal saline irrigation and intranasal corticosteroids 1, 2

Regular blood pressure monitoring is recommended during the tapering process, especially in patients with or at risk for hypertension, as suggested by the American College of Cardiology 1, 2
Monitor for withdrawal symptoms, which may include rebound congestion, headache, or irritability, as noted in the Mayo Clinic Proceedings 3
The American Heart Association, as published in Circulation, advises against stopping the medication abruptly rather than implementing a gradual taper, which may cause rebound symptoms 2